Finance

Lists
EW:NYSE
Edwards Lifesciences Corp
၈၅.၂၇ US$
-၁.၃၀%
(-၁.၁၂) 1D
၈၅.၂၇ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၅  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EW...
Open
၈၆.၅၅ US$
High
၈၆.၇၇ US$
Low
၈၅.၀၇ US$
Mkt. cap
ဋေ ၄.၉၁ ထ
Avg. vol.
၃.၅၀ သန်း
Volume
၃.၆၄ သန်း
P/E ratio
၄၉.၃၃
52-wk high
၉၆.၂၉ US$
52-wk low
၇၂.၄၀ US$
EPS
၁.၇၃ US$
Beta
၀.၈၇
Shares outstanding
၅၇.၆၄ ကုဋေ
No. of employees
၂ သောင်း
Open
၈၆.၅၅ US$
High
၈၆.၇၇ US$
Low
၈၅.၀၇ US$
Mkt. cap
ဋေ ၄.၉၁ ထ
Avg. vol.
၃.၅၀ သန်း
Volume
၃.၆၄ သန်း
P/E ratio
၄၉.၃၃
52-wk high
၉၆.၂၉ US$
52-wk low
၇၂.၄၀ US$
EPS
၁.၇၃ US$
Beta
၀.၈၇
Shares outstanding
၅၇.၆၄ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၄ နာရီ
Edwards Lifesciences Corporation $EW Stock: Sivik Global Healthcare LLC Raises Position
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၁ ရက်
EW Q2 2026 Earnings: Edwards Lifesciences Beats EPS Estimate as Shares Edge Higher - Post-Earnings Reaction
Barchart.com
Barchart.com
·
ပြီးခဲ့သည့် ၁ ရက်
Edwards Lifesciences Earnings Preview: What to Expect
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees၁.၆ သောင်း
Founded၁၉၅၈
Headquartersအိုင်ရာဗင်န်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 17 analysts giving stock ratings to EW in the past 3 months
Strong buy
Buy
14
Hold
3
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for EW in the last 3 months.
Highest
Current ၈၅.၂၇ US$
၁၁၀.၀၀ US$ (+၂၉.၀၀%)
Average
၁၀၄.၀၇ US$ (+၂၂.၀၅%)
Lowest
၈၅.၀၀ US$ (-၀.၃၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Marie Thibault
BTIG
Buy
Reiterated
၁၁၀.၀၀ US$
+၂၉%
10/09/2026
Patrick Wood
UBS
Buy
Maintained
၁၁၀.၀၀ US$
+၂၉%
10/07/2026
Christopher Pasquale
Barclays
Buy
Initiated
၁၁၀.၀၀ US$
+၂၉%
10/07/2026
Matt Miksic
Barclays
Buy
Maintained
၁၁၀.၀၀ US$
+၂၉%
10/07/2026
Tycho Peterson
Jefferies
Buy
Initiated
၁၁၀.၀၀ US$
+၂၉%
10/07/2026
Joanne Wuensch
Citi
Buy
Maintained
၁၁၀.၀၀ US$
+၂၉%
10/05/2026
Kendall Au
RBC Capital
Buy
Maintained
၁၁၀.၀၀ US$
+၂၉%
10/01/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
၁၀၁.၀၀ US$
+၁၈.၄%
09/28/2026
Adam Maeder
Piper Sandler
Buy
Maintained
၁၀၁.၀၀ US$
+၁၈.၄%
09/21/2026
Matthew Taylor
Jefferies
Buy
Maintained
၁၀၅.၀၀ US$
+၂၃.၁%
09/11/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
09/10/2026
William Plovanic
Canaccord Genuity
Hold
Maintained
၈၅.၀၀ US$
-၀.၃%
08/03/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
၁၀၅.၀၀ US$
+၂၃.၁%
07/28/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
၁၁၀.၀၀ US$
+၂၉%
07/24/2026
Suraj Kalia
Oppenheimer
Hold
Maintained
-
-
07/24/2026
Richard Newitter
Truist Financial
Hold
Reiterated
၉၅.၀၀ US$
+၁၁.၄%
07/24/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
၁၁၀.၀၀ US$
+၂၉%
07/23/2026
Travis Steed
Bank of America Securities
Buy
Maintained
၁၀၀.၀၀ US$
+၁၇.၃%
07/21/2026
Josh Jennings
TD Cowen
Buy
Reiterated
၁၀၄.၀၀ US$
+၂၂%
07/23/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
၁၀၅.၀၀ US$
+၂၃.၁%
07/15/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
၁၀၀.၀၀ US$
+၁၇.၃%
07/06/2026
David Roman
Goldman Sachs
Buy
Maintained
၉၈.၀၀ US$
+၁၄.၉%
06/15/2026
Krish Sankar
TD Cowen
Buy
Reiterated
၁၀၄.၀၀ US$
+၂၂%
06/02/2026
David Toung
Argus Research
Buy
Maintained
-
-
05/21/2026
David Rescott
Robert W. Baird
Hold
Maintained
၈၇.၀၀ US$
+၂%
04/24/2026
Michael Polark
Wolfe Research
Buy
Upgraded
၉၂.၀၀ US$
+၇.၉%
04/01/2026
Danielle Antalffy
UBS
Hold
Maintained
၉၀.၀၀ US$
+၅.၅%
02/12/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
၁၀၀.၀၀ US$
+၁၇.၃%
02/11/2026
Last report
၂၀၂၆ ဇူ ၂၃
Fiscal period
Q2 2026
၀.၇၈ US$ / ၀.၇၄ US$
+၅.၁၁%beat
Revenue / Est. (USD)
၁၇၄.၁၀ ဋေ / ၁၆၉.၉၅ ဋေ
+၂.၄၄%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၅၅.၃၁ ဋေ
၁၅၆.၉၆ ဋေ
၁၆၄.၈၆ ဋေ
၁၇၄.၁၀ ဋေ
Cost of goods sold
၃၄.၅၂ ကုဋေ
၃၄.၃၀ ကုဋေ
၃၆.၂၆ ကုဋေ
၃၉.၂၄ ကုဋေ
Cost of revenue
၃၄.၅၂ ကုဋေ
၃၄.၃၀ ကုဋေ
၃၆.၂၆ ကုဋေ
၃၉.၂၄ ကုဋေ
Research and development expenses
၂၈.၀၇ ကုဋေ
၂၆.၇၇ ကုဋေ
၂၆.၃၃ ကုဋေ
၂၇.၈၉ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅၁.၄၆ ကုဋေ
၆၀.၁၂ ကုဋေ
၅၂.၂၂ ကုဋေ
၅၆.၁၂ ကုဋေ
Operating expense
၇၈.၂၈ ကုဋေ
၈၅.၄၆ ကုဋေ
၇၇.၁၃ ကုဋေ
၈၂.၉၁ ကုဋေ
Total operating expenses
၁၁၂.၈၀ ဋေ
၁၁၉.၇၆ ဋေ
၁၁၃.၃၉ ဋေ
၁၂၂.၁၅ ဋေ
Operating income
၄၂.၅၁ ကုဋေ
၃၇.၂၀ ကုဋေ
၅၁.၄၇ ကုဋေ
၅၁.၉၅ ကုဋေ
Other non operating income
၁.၁၀ သန်း
၂.၃၀ သန်း
၆.၉၉ ကုဋေ
-၂.၅၀ ကုဋေ
EBT including unusual items
၃၄.၈၄ ကုဋေ
၉.၀၄ ကုဋေ
၄၅.၉၀ ကုဋေ
၅၁.၉၈ ကုဋေ
EBT excluding unusual items
၄၄.၄၅ ကုဋေ
၄၆.၄၀ ကုဋေ
၆၀.၃၆ ကုဋေ
၅၁.၁၁ ကုဋေ
Income tax expense
၅.၆၁ ကုဋေ
၂.၆၂ ကုဋေ
၇.၈၃ ကုဋေ
၂၇.၈၄ ကုဋေ
Effective tax rate
၁၆.၁၀%
၂၈.၉၈%
၁၇.၀၆%
၅၃.၅၆%
Other operating expenses
-၁.၂၅ ကုဋေ
-၁.၄၃ ကုဋေ
-၁.၄၂ ကုဋေ
-၁.၁၀ ကုဋေ
Net income
၂၉.၁၁ ကုဋေ
၉.၁၂ ကုဋေ
၃၈.၀၇ ကုဋေ
၂၄.၁၉ ကုဋေ
Net profit margin
၁၈.၇၄%
၅.၈၁%
၂၃.၀၉%
၁၃.၈၉%
Earnings per share
၀.၆၇
၀.၅၈
၀.၇၈
၀.၇၈
Interest and investment income
၁.၆၇ ကုဋေ
၁၁.၄၂ ကုဋေ
၁.၇၄ ကုဋေ
၁.၅၀ ကုဋေ
Interest expense
-
-၂.၀၄ ကုဋေ
-
-
Net interest expenses
၁.၆၇ ကုဋေ
၉.၃၈ ကုဋေ
၁.၇၄ ကုဋေ
၁.၅၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၆.၄၃ ကုဋေ
၄၁.၄၇ ကုဋေ
၅၅.၅၆ ကုဋေ
၅၆.၂၂ ကုဋေ
Gain or loss from assets sale
-
-၃.၃၉ ကုဋေ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ